Adverse events after COVID-19 vaccination in the pediatric population in Spain

Introduction: In December 2021, Spain launched its COVID-19 vaccination campaign for children aged 5–11 years. Although the Comirnaty® vaccine exhibited a favorable safety profile in premarketing trials, its rapid deployment and novel mRNA technology raised concerns among the public, leading to pare...

Full description

Bibliographic Details

Main Authors:	M. Ángeles Rivas Paterna, Carla Pérez Ingidua, Ana B. Rivas Paterna, David Ortega Martínez, Esther Aleo Luján, Emilio Vargas Castrillón
Format:	Artigo
Language:	Espanhol
Published:	Elsevier 2026-02-01
Series:	Anales de Pediatría (English Edition)
Subjects:	COVID-19 Vacunas Pediatria Reacciones adversas a medicamentos (RAM) Seguridad Farmacovigilancia
Online Access:	http://www.sciencedirect.com/science/article/pii/S2341287926000189
Tags:	Add Tag No Tags, Be the first to tag this record!